This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Elkins, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Elkins, K. L.

 Previous Article  |  Next Article 

Infection and Immunity, September 2008, p. 4311-4321, Vol. 76, No. 9
0019-9567/08/$08.00+0     doi:10.1128/IAI.00514-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Diverse Myeloid and Lymphoid Cell Subpopulations Produce Gamma Interferon during Early Innate Immune Responses to Francisella tularensis Live Vaccine Strain{triangledown}

Roberto De Pascalis,1* Betsy C. Taylor,2 and Karen L. Elkins1*

Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Research and Evaluation, U.S. FDA, 1401 Rockville Pike, HFM 431, Rockville, Maryland 20852,1 Department of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania 191042

Received 25 April 2008/ Returned for modification 29 May 2008/ Accepted 12 June 2008

Francisella tularensis, a small gram-negative intracellular bacterium responsible for causing tularemia, is highly pathogenic and classified as a category A agent of bioterrorism. As for other intracellular pathogens, successful protective immune responses to Francisella tularensis require rapid and efficient induction of gamma interferon (IFN-{gamma}) production. Studies using intracellular bacteria such as Listeria monocytogenes as well as Francisella suggest that natural killer (NK) and T cells are important sources of IFN-{gamma}. However, comprehensive characterization of specific sources of IFN-{gamma} produced during Francisella infection in vivo remains incomplete, and depletion of NK cells before infection of mice with the F. tularensis live vaccine strain (LVS) has little impact on the course or outcome of infection. In this study, we determined the cell subpopulations that respond quickly to intradermal F. tularensis LVS infection of mice by producing IFN-{gamma} within hours to a few days. Splenic and liver lymphocytes were obtained from LVS-infected mice and analyzed for IFN-{gamma} mRNA by reverse transcription-PCR, for intracellular cytokine expression by multiparameter flow cytometry, and for ex vivo production of IFN-{gamma} protein by enzyme-linked immunosorbent assay. Cells producing IFN-{gamma} were readily detectable by day 3 after infection, and numbers progressively increased through days 5 to 7. Importantly, the cell types responsible for IFN-{gamma} production were much more varied than expected: these included not only NK cells and T cells, which might be predicted, but also other cells, including dendritic cells (DCs), "NK DCs," NK T cells, and neutrophils. Most importantly, since RAG-1 knockout mice appeared to exhibit a frequency of IFN-{gamma}-producing cells comparable to that of intact wild-type mice, early IFN-{gamma} production by innate immune cells does not depend on the presence of T or B cells.


* Corresponding author. Mailing address: Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Research and Evaluation, U.S. FDA, 1401 Rockville Pike, HFM 431, Rockville, MD 20852. Phone for Roberto De Pascalis: (301) 496-5850. Fax: (301) 435-5675. E-mail: roberto.depascalis{at}fda.hhs.gov. Phone for Karen L. Elkins: (301) 496-0544. Fax: (301) 435-5675. E-mail: karen.elkins{at}fda.hhs.gov

{triangledown} Published ahead of print on 23 June 2008.

Editor: W. A. Petri, Jr.


Infection and Immunity, September 2008, p. 4311-4321, Vol. 76, No. 9
0019-9567/08/$08.00+0     doi:10.1128/IAI.00514-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J.-D., Iwakura, Y., Metzger, D. W., Monack, D. M. (2010). Type I IFN Signaling Constrains IL-17A/F Secretion by {gamma}{delta} T Cells during Bacterial Infections. J. Immunol. 184: 3755-3767 [Abstract] [Full Text]  
  • Wickstrum, J. R., Bokhari, S. M., Fischer, J. L., Pinson, D. M., Yeh, H.-W., Horvat, R. T., Parmely, M. J. (2009). Francisella tularensis Induces Extensive Caspase-3 Activation and Apoptotic Cell Death in the Tissues of Infected Mice. Infect. Immun. 77: 4827-4836 [Abstract] [Full Text]  
  • Sharma, J., Li, Q., Mishra, B. B., Georges, M. J., Teale, J. M. (2009). Vaccination with an Attenuated Strain of Francisella novicida Prevents T-Cell Depletion and Protects Mice Infected with the Wild-Type Strain from Severe Sepsis. Infect. Immun. 77: 4314-4326 [Abstract] [Full Text]  
  • Collazo, C. M., Meierovics, A. I., De Pascalis, R., Wu, T. H., Lyons, C. R., Elkins, K. L. (2009). T Cells from Lungs and Livers of Francisella tularensis-Immune Mice Control the Growth of Intracellular Bacteria. Infect. Immun. 77: 2010-2021 [Abstract] [Full Text]  
  • Vojtech, L. N., Sanders, G. E., Conway, C., Ostland, V., Hansen, J. D. (2009). Host Immune Response and Acute Disease in a Zebrafish Model of Francisella Pathogenesis. Infect. Immun. 77: 914-925 [Abstract] [Full Text]